NCT05878392 is a NA clinical trial of bone filling materials in Immediate Implant, sponsored by Mansoura University.

Who is sponsoring NCT05878392?

NCT05878392 is sponsored by Mansoura University.

What drugs are being tested in NCT05878392?

Interventions in NCT05878392: bone filling materials.

What condition does NCT05878392 study?

NCT05878392 studies Immediate Implant.

Is NCT05878392 still recruiting?

NCT05878392 is currently completed. Last updated 26 May 2023.

Last reviewed 2023-05-26 · How we verify

NCT05878392

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immediate Implant With Different Filling Materials

Completed NA Last updated 26 May 2023

What this trial tests

NA trial testing bone filling materials in Immediate Implant in 36 participants. Completed in 1 January 2023.

Timeline

1 January 2022

Primary endpoint
1 June 2022

1 January 2023

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	36
Start date	1 January 2022
Primary completion	1 June 2022
Estimated completion	1 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

bone filling materials

Conditions studied

Immediate Implant — all drugs for Immediate Implant →

Sponsor

Mansoura University

Who can join

Adults 18 to 45, any sex, with Immediate Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

36 patients, were included in this study. They were chosen from the Outpatient Clinic in the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University for replacement of non-restorable maxillary anterior and premolar teeth (esthetic zone) by immediate implant.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Comparison between platelet rich fibrin as space filling material versus xenograft and alloplastic bone grafting materials in immediate implant placement: a randomized clinical trial.
Elsheikh HA, Abdelsameaa SE, Elbahnasi AA, Abdel-Rahman FH. · · 2023 · cited 8× · PMID 38066454 · DOI 10.1186/s12903-023-03678-5
Comparison Between Platelet Rich Fibrin as Space Filling Material Versus Xenograft and Alloplastic Bone Grafting Materials in Immediate Implant Placement: A Randomized Clinical Trial
Elsheikh HA, Abdelsameaa SE, Elbahnasi AA, Abdel-Rahman FH. · · 2023 · DOI 10.21203/rs.3.rs-3313541/v1

Verify or expand the search:

Other recruiting trials for Immediate Implant

Currently open trials in the same condition.

NCT06588998 — Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implan · Phase 2 · recruiting
NCT06700486 — Assessment of the Socket Shield Technique Accompanied by Sticky Bone Around the Immediate Implant · NA · active not recruiting

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05878392 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 26 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05878392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing